Zosano Pharma Corp: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2021)
- $785.0K
- Net Income/Loss (FY2021)
- -$29.9M
- Total Assets (FY2021)
- $48.4M
- Total Equity (FY2021)
- $33.0M
- Cash Flows from Operating Activities (FY2021)
- -$27.6M
Source: Zosano Pharma Corp 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
